Cargando…
Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB(2) receptor agonist ABK5
Cannabinoid receptors are a potential target for anti-inflammatory and pain therapeutics. There are two subtypes, CB(1) and CB(2), and Δ(9)-tetrahydrocannabinol activates both of them, providing an analgesic effect but also psychoactive side effects. The psychoactive side effects are considered to b...
Autores principales: | Tang, Yaliang, Wolk, Barbara, Britch, Stevie C., Craft, Rebecca M., Kendall, Debra A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376191/ https://www.ncbi.nlm.nih.gov/pubmed/33712283 http://dx.doi.org/10.1016/j.jphs.2020.12.006 |
Ejemplares similares
-
Effects of a CB(2) Subtype Selective Agonist ABK5-1 on Cytokine Production in Microglia
por: Tang, Yaliang, et al.
Publicado: (2021) -
Characterization of Subtype Selective Cannabinoid CB(2) Receptor Agonists as Potential Anti-Inflammatory Agents
por: Tang, Yaliang, et al.
Publicado: (2021) -
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016) -
Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
por: Reichenbach, Zachary W., et al.
Publicado: (2022) -
Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
por: Capozzi, Antonella, et al.
Publicado: (2021)